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Abstract
Highly pathogenic avian influenza (HPAI) A(H5N1) viruses pose a significant economic burden to the poultry industry
worldwide and have pandemic potential. Poultry vaccination against HPAI A(H5N1) viruses has been an important
component of HPAI control measures and has been performed in Vietnam since 2005. To systematically assess
antigenic matching of current vaccines to circulating field variants, we produced a panel of chicken and ferret antisera
raised against historical and contemporary Vietnamese reference viruses representing clade variants that were
detected between 2001 and 2014. The antisera were used for hemagglutination inhibition (HI) assays to generate data
sets for analysis by antigenic cartography, allowing for a direct comparison of results from chicken or ferret antisera. HI
antigenic maps, developed with antisera from both hosts, revealed varying patterns of antigenic relationships and
clustering of viruses that were dependent on the clade of viruses analyzed. Antigenic relationships between existing
poultry vaccines and circulating field viruses were also aligned with in vivo protection profiles determined by
previously reported vaccine challenge studies. Our results establish the feasibility and utility of HPAI A(H5N1) antigenic
characterization using chicken antisera and support further experimental and modeling studies to investigate
quantitative relationships between genetic variation, antigenic drift and correlates of poultry vaccine protection
in vivo.
Introduction
Antigenic drift is the Achilles’ heel of designing effective
vaccines against rapidly evolving pathogens, such as
influenza viruses. In poultry vaccination programs, the
challenges are particularly acute when significant genetic
variation exists among co-circulating strains, as is the case
for highly pathogenic avian influenza (HPAI) A(H5N1)
viruses. Antigenic matching, which refers to the antigenic
similarity between a given vaccine strain and circulating
field viruses, is typically measured by raising antisera in
animal models and subsequently comparing antibody-to-
antigen reactivity titers of the vaccine strain (homologous
titer) vs. circulating field viruses (heterologous titers). For
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many decades, human seasonal influenza virus antigenic
matching has relied on hemagglutination inhibition (HI)
assays using ferret antisera as the gold standard for
measuring variation among viruses1,2. Twice each year,
the World Health Organization (WHO) Global Influenza
Surveillance and Response System (GISRS), in conjunc-
tion with Collaborating Centres for Influenza and Essen-
tial Regulatory Laboratories, produces genetic and
antigenic analyses of viruses to systematically review
diversity of influenza B and influenza A viruses (IAVs)
from the Northern and Southern hemispheres, and
recommends the antigen formulation for human seasonal
influenza vaccines. The recommendations also include a
selection of specific candidate vaccine viruses (CVVs) for
non-seasonal influenza virus subtypes and genetic linea-
ges as a precautionary measure to produce at-the-ready
vaccine seed viruses for pandemic vaccine preparedness3.
Ferrets are the preferred animal model to study the sus-
ceptibility, virulence and transmission of IAVs because they
are highly susceptible to both human and potentially zoonotic
IAVs and experience similar clinical outcomes and immune
responses to those of humans4. However, the production of
ferret antisera is expensive and requires animal biocontain-
ment laboratories, which is needed in part to prevent
unwanted exposure of naive ferrets to circulating seasonal
viruses. The importation of serologically influenza-naive (and
specific pathogen free) ferrets into Vietnam is complicated
due to customs procedures and the likelihood of infection
during transport. Available animal containment facilities
within Vietnam are also limited in space and resources, and
there are currently no commercial entities that raise labora-
tory animals under containment for research purposes. Thus,
the ferret model of infection is currently unavailable in
Vietnam, and representative panels of ferret antisera are rarely
available. Because chickens are the principle target for HPAI
poultry vaccination and are readily available, they are an ideal
animal model for producing reference antisera to evaluate
antigenic variation among viruses and vaccines, host immune
responses, and vaccine efficacy5. In this study, we aimed to
produce antisera in chickens against representative HPAI A
(H5N1) clade variants at the National Centre for Veterinary
Diagnostics (Hanoi, Vietnam) and to use these antisera to
characterize circulating HPAI A(H5N1) Vietnamese viruses
by HI assay and antigenic cartography. We compared anti-
genic relationships among viruses using panels of ferret versus
chicken antisera to explore the utility and feasibility of HI
testing with chicken antisera to antigenically match currently
available poultry vaccines used in Vietnam with circulating
strains.
Results
Collection and preliminary analysis of chicken antisera
The average volume of antiserum collected from indi-
vidual chickens was 6.5 ml (ranging from 4 to 13ml).
Mean HI titers induced by heterologous viruses varied
from 1:40 to 1:640 (Table 1). In ferrets, homologous HI
titers varied from 1:160 to 1:1280, while in chickens,
homologous HI titers varied from 1:40 to 1:1280
(Table 1). For 4 of 14 viruses (29%), the homologous HI
titers raised in chickens and ferrets were equivalent (with
titers ranging from 1:320 to 1:1280). For 8 of 14 viruses
(57%), the homologous virus HI titer raised in ferrets was
higher than that obtained in chickens (ranging from 2- to
8-fold higher), while for 2 of 14 viruses (14%), the antisera
raised in chickens yielded higher homologous HI titers
(ranging from 2- to 4-fold differences, see Table 1).
Antigenic analysis of HPAI A(H5N1) virus isolates
Ferret-based map
The antigenic distances between viruses based on HI
analyses using ferret antisera are displayed in Fig. 1.
Viruses within clades 1, 2.3.2.1, 2.3.4 and 7.1 were greatly
inhibited by antisera raised in ferrets against viruses from
the same clade, indicating close antigenic relationships
within each clade (Fig. 1). Clade 1 viruses reacted well
against clade 1 heterologous antisera within a 2- or 4-fold
antigenic distance in ferret-based maps. Clade 2.3.2.1
viruses in the ferret-based map are clustered relatively
closely, reflecting the high cross-reactivity among viruses
of this group. This clade produced heterologous titers
within two-fold of viruses among this subclade, but
exhibited lower reactivity to more genetically distant
clades. Clade 2.3.4 viruses reacted with patterns indicative
of the genetic diversity found among viruses in this group.
Although viruses clustered with those of the same sub-
clade, among the various 2.3.4 subclades (i.e., 2.3.4.1,
2.3.4.2, and 2.3.4.3), there were greater antigenic distances
(Fig. 1). The antisera produced against clade 2.3.4 viruses
also reacted with high specificity for related viruses,
although some clade 1 viruses were an exception (Fig. 1).
Antisera against clade 7.1 viruses cross-reacted within this
clade, but these viruses were outliers compared to all the
other clades.
The use of ferret antisera for one-way analyses of
additional test antigens yielded heterologous HI titers of
sera against related and unrelated HPAI A(H5N1) within
clade viruses, ranging from equivalent to 64-fold titer
differences compared to homologous titers. From the
ferret antisera-based map (Fig. 1), we observed that the
majority of clade 2.3.2.1 (86%, n= 12/14) and clade 7.1
(67%, n= 2/3) viruses clustered closely with heterologous
titers, within two-fold of homologous titers of genetically
related viruses. Clade 2.3.4 and 1 viruses clustered close to
each other, although variation was still observed within
each clade and subclade. Eight of nine clade 2.3.4 viruses
in the ferret antisera-based map were inhibited by antisera
against other clade 2.3.4 viruses at titers within 4-fold of
each other.
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Chicken-based map
Two-way analyses of chicken antisera and the chicken
antisera-based map (Fig. 2; Supplemental Table 2) showed
a similar trend of within-clade clustering as that observed
in the ferret antisera-based map (Fig. 1) for clades 1,
2.3.2.1, 2.3.4 and 7.1. The clade 1 viruses displayed shorter
intra-clade antigenic distances (4-fold differences) than
HI tests with ferret antisera (8-fold distances), which may
be explained by the inclusion of additional clade 1.1.1 and
1.1.2 antigens in chicken HI tests. Similarly, the majority
(73%, n= 8/11) of clade 2.3.2.1 viruses mapped within 4-
fold of each other, while some viruses (27%, n= 3/11)
showed 8-fold reduced titers relative to other viruses
within clade 2.3.2.1. Clade 2.3.4 viruses showed strong
intra-clade clustering (6 of 8 viruses were within 4-fold of
clade 2.3.4 antisera), whereas two clade 2.3.4 antisera had
8-fold reduced titers relative to other clade 2.3.4 viruses
(Fig. 2). Clustering of clade 2.3.2.1b viruses was less
evident than for viruses of clades 2.3.2.1a and 2.3.2.1c.
The estimated coordinates of the Re-6 vaccine virus
(based on the nearest homologous strain of 2.3.2.1b)
exhibited average geometric mean titers with a 5-fold
difference to other viruses within the subclade. HPAI A
(H5N1) viruses included on the map that have never
circulated in Vietnam (i.e., the Egyptian clade 2.2.1 and
Indonesian clade 2.1 viruses) and were not inhibited by
heterologous antisera (i.e., sera from outside the clade)
and vice versa. Thus, the clade 2.2.1 and 2.1 viruses did
not show a consistent pattern of clustering across the
chicken and ferret maps.
The Re-1 vaccine antigen (clade 0) was greatly inhibited
by antisera raised against both clade 1 and 2.3.4 viruses,
and the antisera raised with the Re-1 vaccine showed a
reciprocal inhibition of both clade 1 and 2.3.4 antigens. In
contrast, antisera against Re-1 showed little-to-no inhi-
bition of clade 2.3.2.1 and 7.1 viruses. The Re-5 antisera
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Fig. 1 Antigenic maps of influenza A(H5N1) HA based on HI immune responses to chicken antisera. Both vertical and horizontal axes
represent antigenic distance. Grid lines represent 1 antigenic distance unit, corresponding to a 2-fold dilution in the HI assay. Different antigenic
clusters are indicated with different colors. Filled circles indicate antigens, while open squares indicate antisera
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(clade 2.3.4) reacted well against clade 1 and clade 2.3.4
antigens, whereas Re-6 antisera (clade 2.3.2.1b) antiserum
reacted well with only the clade 2.3.2.1 antigens. Clade 7.1
viruses demonstrated relatively close antigenic relation-
ships to one another but were outliers compared to all
other clades; the three data points on the chicken
antisera-based map demonstrated relatively close anti-
genic relationships to one another (Fig. 2).
For the one-way HI analyses (Supplemental Table 2),
comparable titer profiles were observed for all members
of clade 1, 1.1.1 and 1.1.2 viruses. Similarly, the thirty-nine
test antigens from clade 2.3.2.1 viruses (comprising 10
clade 2.3.2.1a, 7 clade 2.3.2.1b and 22 clade 2.3.2.1c
viruses), demonstrated moderate reactivity with most of
within-clade heterologous antisera (64%, n= 7/11), with
titers that were within 4-fold of each other. In contrast,
the antigens had no reactivity to clade 1, 2.3.4 and 7
viruses. The clade 2.3.2.1a viruses separated into two
antigenic clusters, whereas the clade 2.3.2.1c viruses
overlapped within 2-fold of each other on the chicken
antisera-based antigenic map and also clustered with
some clade 2.3.2.1a viruses (Fig. 2). The clade 2.3.2.1b
viruses were antigenically distinct from other clade 2.3.2.1
viruses. Similar to observations made in the two-way
analyses, clade 2.3.2.1a and 2.3.2.1b viruses clustered
together within 4-fold of one another but had greater
antigenic distances compared to clade 2.3.2.1c viruses
(within 2-fold). Clade 7.2 viruses had no reactivity to the
clade 7.1 antisera tested. Although the clade 2.3.2.1b A/
duck/Vietnam/NCVD-672/2011 virus reacted well with
the genetically related clade 2.3.2.1b viruses, it was an
outlier with respect to the other viruses of this clade, as it
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Fig. 2 Antigenic maps of influenza A(H5N1) HA based on HI immune responses to ferret antisera. Both vertical and horizontal axes represent
antigenic distance. Grid lines represent 1 antigenic distance unit, corresponding to a 2-fold dilution in the HI assay. Different antigenic clusters are
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did not react well with antisera raised against clade
2.3.2.1a or 2.3.2.1c viruses (with 8- to 64-fold reductions
observed compared to heterologous HI titers of clade
2.3.2.1a and 2.3.2.1c antisera). These relationships can be
observed from the HI data matrices as well as the chicken
antisera-based antigenic map (Fig. 2).
Similar to the results of the two-way HI titer compar-
ison, vaccine antisera raised against Re-1 and Re-5
showed inhibition of their respective clade 1 and 2.3.4
antigens. Re-6 antiserum showed specific reactivity with
only the clade 2.3.2.1 viruses. Clade 7.1 viruses were
antigenically related to each other and remained outliers
compared to all other clades. For viruses that have never
circulated in Vietnam (i.e., clade 2.2, 2.2.1, 2.1.3), little
reactivity to Vietnamese clade viruses was observed. In
general, the results of the two-way and one-way analyses
generated from HI tests using chicken antiserum panels
were compatible to those produced with ferret antisera.
Combined chicken and ferret antisera-based map
In general, the homologous HI titers indicated that four
of fourteen pairs (28%) of chicken/ferret antisera had
identical homologous HI titers (with titers ranging from
1:320 to 1:1280); eight pairs (57%) had higher HI titers in
ferrets than in chickens, ranging from 2- to 8-fold higher
(2 pairs had a 2-fold difference, 2 pairs had a 4-fold dif-
ference and 4 pairs had 8-fold difference); and 2 pairs
(14%) had higher HI titers in chickens compared to ferrets
(1 pair had a 2-fold difference and 1 pair had 4-fold dif-
ference). Side by side comparisons of chicken and ferret
antisera run in the same HI test are shown in Fig. 3. The
majority of antiserum pairs mapped to within proximate
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locations of each other (71%, n= 10/14). Antiserum pairs
for clades 7.1 (n= 1), 1 (n= 1) and 0 (n= 1) showed
nearly identical positions, as did most pairs in clades
2.3.2.1 (n= 3/5) and 2.3.4 (n= 1/2). However, three
antigens that had homologous HI titers within 4- to 8-fold
between chicken and ferret antisera pairs displayed
greater fold reductions in side by side comparisons of
heterologous titers generated from one-way testing of
viruses. For instance, the clade 2.3.2.1 A/Hong Kong/
6841/2010 (HK/6841) antigen had identical homologous
titers to the chicken/ferret antiserum pair. However, the
ferret antiserum displayed broad reactivity against unre-
lated clade viruses, whereas the chicken antiserum did
not. Similarly, the clade 2.3.2.1b, A/duck/Vietnam/
NCVD-672/2011 antiserum pairs had homologous HI
titers within 4-fold of each other, while heterologous titers
with non-clade 2.3.2.1 viruses varied from 8- to 32-fold, as
expected. In particular, the ferret antiserum was able to
inhibit clade 2.3.4 viruses, whereas chicken antisera did
not. Together, these results suggest that this virus did not
produce clade-specific antisera in either the chicken or
ferret model. The clade 2.3.4 A/duck/Vietnam/NCVD-
293/2009 virus also resulted in greater fold reductions
(between 8- and 32-fold differences) in HI titers when
comparing the reactivity of chicken and ferret antisera.
Further analysis of the HI table indicated that 90% of all
antigens (n= 38/42) were broadly inhibited by the A/
duck/Vietnam/NCVD-293/2009 chicken antiserum, thus
confounding the relative distance measures to different
strains. Because the ferret HI included only two clade
2.3.4 viruses compared with the eight clade 2.3.4 viruses
used in the chicken-based map, a direct comparison
between chicken sera and ferret sera was not possible for
these viruses. Another virus, clade 2.1.3.2 A/Indonesia/5/
2005, also displayed greater fold reductions (between 8-
and 32-fold differences) when comparing the reactivity of
the homologous chicken and ferret antisera. The HI table
shows that this virus produced a very high homologous HI
titer of 1:1280 in the ferret, whereas the immune response
in the chicken produced a titer of 1:160 (8-fold differ-
ence). This could be an anomaly in the ferret antiserum
produced against this virus, suggesting that careful eva-
luation of initial homologous titers is warranted prior to
use in routine HI testing.
Antigenic distances vs. vaccine efficacy in chickens
For both ferret- and chicken-based antigenic analyses,
the operative question posed by these studies is the degree
to which the measured antigenic distances are useful for
predicting the protective efficacy of different vaccine
formulations. In vivo poultry vaccine challenge studies are
performed by the Vietnamese Department of Animal
Health on an annual or biannual basis to examine the
protection afforded by poultry vaccines against viruses
belonging to selected A(H5) clades and/or antigenic var-
iants6–9. The compiled results of such studies are shown
in Fig. 4, where percent survival is plotted against the
‘cartographic’ antigenic distance between a vaccine and
the challenge virus. These studies have demonstrated that
Re-1 (clade 0)-vaccinated chickens were protected against
death when challenged with either clade 1 or clade
2.3.2.1a and 2.3.2.1c viruses (100% survival in all cases),
whereas Re-1 was less effective against two clade 2.3.2.1b
viruses (30%, n= 3/10) (Fig. 4). The clade 1 challenge
viruses had antigenic distances to Re-1 that were ≤1.4
HAUs. The antigenic distance between the Re-1 vaccine
strain and the clade 2.3.2.b viruses was ≥3.5 HAU,
whereas the antigenic distances of other clade 2.3.2.1
challenge viruses were less. Similarly, the Re-5 (clade
2.3.4) vaccine provided good protection against clade 1
viruses (90%, n= 90/10) but less protection against clade
2.3.2.1 viruses (70–90%, n= 7–9/10 against clade 2.3.2.1a;
10–30%, n= 1–3/10 against clade 2.3.2.1b; and 30–90%,
n= 3–9/10 against clade 2.3.2.1c viruses). Re-5 challenge
viruses, resulting in 30% or less survival, had antigenic
distances to Re-5 between 3.7–4.1 HAUs, while those
with 70–90% survival had distances ranging from 1.5–3.2
HAUs (Fig. 4). The Re-6 (clade 2.3.2.1b) vaccine protected
chickens against clade 2.3.2.1a, b and c viruses (90–100%,
9–10/10), but was less effective (30–50%, n= 3–5/10)
against clade 1 viruses. The clade 1 viruses tested had
antigenic distances of >4.9 HAUs, whereas all other
Fig. 4 Antigenic distances between vaccine and challenge viruses
plotted against vaccine efficacy (percent survival), as determined
by in vivo vaccine challenge experiments. Each data point
represents results from a challenge trial using 10 chickens/challenge
virus and survival following intranasal inoculation with a dose of 106
TCID50. Blue diamonds, red squares and green triangles represent
chickens vaccinated with Re-1, Re-5 and Re-6, respectively. The
challenge viruses used are identified for each group of vaccinated
chickens with color-coded text indicating strain name and clade
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challenge viruses were antigenically closer to the Re-6
vaccine strain (Fig. 4).
Discussion
Vietnam is one of four countries (along with China,
Egypt and Indonesia) where poultry vaccination has
become a routine practice to control HPAI A(H5) viruses.
To date, most government-supported poultry vaccination
programs in Vietnam have employed inactivated, oil-in-
water emulsion vaccines imported from the Harbin
Veterinary Research Institute in China, which have been
periodically updated and reformulated in an attempt to
optimize antigenic matching following shifts in pre-
dominant H5 clade circulation in China. Phylogenetic
analyses of codon-complete genome sequences of A(H5)
viruses isolated from poultry outbreaks in Vietnam have
identified a total of 56 genotypes and a circulation of at
least 16 distinct clades10–16. From 2012 to 2015, six clades
(1.1.2, 2.3.2.1a-c, 2.3.4.4 and 7.2) circulated, and the most
recent surveillance data showed that clades 2.3.2.1c and
2.3.4.4 viruses predominated in 2015 and 201613. Given
the rapid evolution and frequent introduction of new A
(H5) clades, maintaining a comprehensive panel of
reference ferret antisera for antigenic characterization of
viruses is crucial to assess antigenic matching of existing
poultry vaccines. However, despite the importance of
these reagents for successful vaccine strain selection and
implementation policies, production of these panels
remains resource-intensive and expensive to generate. To
explore the utility of chicken antisera as a cost-effective
strategy to meet these research goals, we ran HI assays
using both chicken and ferret antisera and compared their
ability to discriminate between antigenically distinct
viruses using antigenic cartography.
Our results indicated that antigenic distances calculated
using multidimensional scaling or ‘mapping’ approaches
generated similar results for both the chicken and ferret
HI data sets. In both instances, antigenic clustering cor-
responded to genetic grouping as determined by HA
phylogenies. Clade 2.3.2.1 viruses were inhibited by anti-
sera raised against clade 2.3.2.1 viruses at titers within 4-
fold of each other but exhibited little or no cross-reactivity
to clade 1, 7 and 2.3.4 viruses. Cross-HI tests of 2.3.2.1
viruses yielded heterologous titers within two-fold of
homologous titers of genetically related viruses; these HI
results translated into average intra-clade antigenic dis-
tance measures of 2.13 antigenic distance unit (ADU)
(ranging from 0.15 to 4.95) on the antigenic map, vs.
inter-clade differences of 3.84 ADU (ranging from 0.53 to
9.01). While clade 2.3.2.1c viruses exhibited a high degree
of homogeneity in antigenic profiles (both serum and
antigen points were tightly clustered), the 2.3.2.1a and
2.3.2.1b clades were not consistently inhibited by 2.3.2.1c
antisera and vice versa (Fig. 1). Clade 1 viruses clustered
together with titers within 4-fold of each other. Cross-HI
tests of chicken antisera raised against clade 2.3.4 viruses
showed strong intra-clade clustering (6 of 8 viruses were
within 4-fold of clade 2.3.4 antisera), except for two clade
2.3.4 antisera that had 8-fold reduced titers against the
clade 2.3.4 viruses.
Although analyses of the chicken and ferret antisera
showed consistent reactivity patterns among tested the
viruses and yielded similar comparisons of antigenic
groupings, differences in reactivity and relative map
positions were observed for 4 of the 14 chicken and
ferret antisera pairs. For example, ferret antisera were
unable to resolve antigenic differences between clade 1
and 2.3.4 viruses, which had overlapping antigenic
space compared to the clearly defined delineation
between these two clades using chicken antisera (Fig. 1,
Fig. 2). On the other hand, clade 2.3.2.1 viruses clus-
tered well in antigenic maps from ferret HI tests (within
1 antigenic unit) but were more widely dispersed in
tests performed with chicken antisera. Variation in
reactivity profiles of chicken vs. ferret antisera may be
attributable to differences in antisera production. First,
the production of ferret antisera, involved the inocu-
lation of ferrets with live virus, followed by an adju-
vanted boost 14 days post-infection. In contrast, the
production of antisera in chickens required that inac-
tivated virus be used for inoculation, as HPAI viruses
cause fatal infections in chickens, which would have
abrogated the possibility of collecting influenza-specific
serum antibodies. Ferrets, on the other hand, experi-
enced infections with the wild-type viruses that likely
triggered both innate and cell-mediated immunity and
stimulated pattern recognition receptors in a manner
similar to natural infection. The production of refer-
ence anti-sera in chickens requires that they be
immunized with an inactivated antigen due to the
extreme lethality of HPAI A(H5) infections in chickens.
Thus, the immune response measured by our chicken-
based maps more closely mimicked vaccine-induced
immunity rather than natural infection. These differ-
ences may be expected to impact the overall antibody
titer but not the specificity of the serum antibodies.
Although live virus infections may stimulate a broader,
more robust immune response in chickens and reflect a
natural infection, its practical application for generating
antisera may be less advantageous. Utilization of a live
virus requires that attenuated, reassortant/reverse
genetics viruses are available because of the lethality of
HPAI A(H5) viruses in chickens. In resource-limited
situations, genetically modified, attenuated strains are
expensive and time-consuming to produce, whereas
inactivated virus is easily obtained from field strains.
Furthermore, because poultry vaccines used in Vietnam
rely on inactivated vaccine formulations, the generation
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of antisera with inactivated virus may be a better model
of the post-vaccination immune response and better
reflect the immune response to vaccination in the field.
A direct comparison of antisera raised in ferrets using
inactivated virus as an immunogen was not possible
due, in part, to existing protocols approved by the
Institutional Animal Care and Use Committee of the
CDC that require the use of infectious virus but, more
importantly, because previous studies showed that
inactivated virus did not consistently elicit sufficient HI
antibody titers when given intranasally (data not
shown). A second important methodological difference
was the use of different adjuvants for the ferrets and
chickens. Adjuvants are compounds that have been
shown to non-specifically augment host responses17.
The precise mechanisms and differences between
adjuvanted and non-adjuvanted responses have rarely
been defined, and the impact they may have on the
breadth of antibody coverage or specificity of the
response is rarely measured with precision. For the
experiments reported in this study using ferret antisera,
Titermax Gold adjuvant was used in the boost inocu-
lum, while the adjuvant used to produce reference
chicken antisera was MontanideTM ISA 70 VG. Both
TiterMax Gold (http://www.titermax.com/technical-
information.html) and MontanideTM ISA 70 VG have
been developed to create stable water-in-oil (W/O)
emulsions. Although both adjuvants are metabolized in
a similar fashion, it has not been assessed whether their
use results in differences in antigenic cross-reactivity of
serum antibodies. Finally, besides the methodological
differences noted, there is likely to be some variation in
how the ferret immune system targets viral epitopes
compared to that of chickens. Host-specific variation in
antigen processing, antibody production, and ulti-
mately, the specificity of an antibody for an antigen may
lead to variation in HI reactivity patterns between
antisera raised in each host.
Plotting of the antigenic distance relative to percent
survival of chickens post-vaccine challenge demonstrated
an inverse relationship between survival rate and anti-
genic distance. In general, the comparison of antigenic
distances and percent survival of chickens following vac-
cine challenge suggested a trend toward lower survival
rates as the antigenic distance between a challenge virus
and vaccine virus increased. Indeed, aggregate results of
in vivo challenge studies showed that Re-1 (clade 0) reli-
ably protected chickens against clinical disease when
challenged with either clade 1 or clade 2.3.2.1a and c
viruses, but protection against clade 2.3.2.1b viruses was
reduced when antigenic distances exceeded 3.5 units. The
Re-5 (clade 2.3.4) vaccine provided good protection
against clade 1 viruses but was more variable and less
protective in experiments using the clade 2.3.2.1 a, b and c
challenge viruses. Challenge viruses resulting in 30 to 10%
survival had antigenic distances to the vaccine strain
beyond 3.5 HAUs. The Re-6 (clade 2.3.2.1b) vaccine
protected chickens against challenge with clade 2.3.2.1a, b
and c viruses but only partially protected birds from clade
1 virus challenges. The infection of chickens with clade 1
viruses, which were the most antigenically distant to the
vaccine strains in this study, resulted in poor protection.
Additional studies assessing a larger number of challenge
viruses and more recent poultry vaccines are warranted.
The predicted protection profile of vaccines challenged
with clade 2.3.4.4 viruses, which have spread into North
America and continue to spread in Europe, Africa and
Asia, is of particular interest, as this was the predominant
clade circulating in Vietnam in 2016, as evidenced by the
extensive national active surveillance system in live bird
markets (LBM)13. Additional HI test data with these
viruses is needed to further assess the correlation between
antigenic distances and the in vivo protection of poultry
vaccines when chickens are challenged with clade 2.3.4.4
viruses. The antigenic data presented in this study sup-
ports current recommendations for use of the Re-6
(2.3.2.1b) vaccine for outbreaks of clade 2.3.2.1c viruses,
but additional data are needed to assess circulating strains
of clade 2.3.4.4 viruses. A new bivalent vaccine formula-
tion, Re-8 (derived from clade 2.3.4.4 A(H5N6) A/
chicken/Guizhou/4/2013 mixed with Re-6), is currently
under evaluation and shows promise for generating
broader protection against antigenically diverse viruses.
What remains to be seen is whether the precise quanti-
tative measures of antigenic distances, as afforded by the
cartographic analyses presented here, could be used to
model and predict outcomes from experimental challenge
studies. For example, it should be feasible to examine,
compare, and visualize how the breadth of immunity
induced by bivalent vaccine formulations (i.e., comprising
two A(H5) clade variants) differs from immune responses
to monovalent formulations through an antibody land-
scaping approach that builds upon the A(H5) maps pre-
sented here.
In summary, our data demonstrate the utility of using
panels of reference chicken antisera for the systematic
analysis of antigenic drift variants of A(H5) viruses and
indicates that the chicken- and ferret-based antiserum
panels used in HI assays yielded comparable antigenic
profiles, which were relevant for evaluating A(H5) vaccine
antigenic matches. The great advantage of using antisera
raised in chickens for these analyses is the feasibility of
generating the antigenic data quickly in-country and
within the existing constraints and resources of national
animal health laboratories in Vietnam. We strongly
advocate for more integrated analyses of antigenic dis-
tance measures based on cartography, together with
output from in vivo transmission studies, to develop
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reliable surrogate markers of protective immunity and
standardized measures of vaccine performance. Strategic
use of new computational tools is needed to meet the long
term goal of achieving robust vaccine-induced hetero-
subtypic immunity and to overcome the Achilles’ heel of
antigenic drift.
Materials and methods
Viruses
A total of 85 Vietnamese HPAI A(H5N1) viruses were
selected to represent the historical and contemporary
diversity of hemagglutinin (HA) clades/subclades from
2001-201418. Fifteen additional non-Vietnamese A(H5)
viruses were also included, representing ancestral (proto-
type) clades and viruses from Indonesia and Egypt that
have not circulated in Vietnam. In total, the panel of
viruses represented 21 out of 22 existing A(H5) clades. The
poultry vaccines evaluated in this study were produced by
the Harbin Veterinary Research Institute in Harbin, China,
consisting of inactivated reverse engineered vaccine con-
structs that were generated using the A/Puerto Rico/8/
1934 (PR8) backbone and the HA and NA genes from
various A(H5) clades. The vaccines of interest were Re-1
(A/goose/Guangdong/1/1996, clade 0), Re-5 (A/duck/
Anhui/1/2006, clade 2.3.4), Re-6 (A/duck/Guangdong/
S1322/2006, clade 2.3.2.1b) and Re-4 (A/chicken/Shanxi/2/
2006, clade 7.1). As we did not have access to the vaccine
viruses for Re-4, Re-5, or Re-6, the following closely related
viruses were used as surrogates (>99% identical HA
nucleotide sequences): Re-5 (A/Anhui/1/2005, clade 2.3.4),
Re-4 (A/chicken/Vietnam/NCVD-016/2008 IDCDC-
RG12, clade 7.1) and Re-6 (A/barn-swallow/Hong Kong/
D10-1161/2010, clade 2.3.2.1b).
Antigen preparation
Viruses were grown in 9- or 10-day-old influenza-free,
clean-embryonated chicken eggs (C-ECE). Ten C-ECEs
per isolate were used, and the allantoic fluid was harvested
from each C-ECE after incubation at 37 °C for 48–72 h.
After harvesting, viruses were inactivated with beta-
propiolactone (BPL) at a final concentration of 0.05%
for 4 h at 37 °C, after which the virus samples were stored
at 4 °C overnight and then adjusted to pH 7.2 using a
sterile 7.5% NaHCO3 solution. Inactivation was confirmed
through three serial egg passages without any evidence of
viral growth as detected by HA. Inocula for chicken
antisera production were prepared by mixing inactivated
antigens [at 1280 hemagglutination units (HAU)] with an
adjuvant (Montanide ISA 70) in a 3:7 v:v ratio, which were
emulsified by sonication for 15–20 s as per manufacturer’s
instructions (http://www.seppic.com/animal-health/
vaccine-adjuvant/montanide-isa/-montanide-isa-70-vg).
The emulsified antigen-adjuvant mixtures were stored at
4 °C and used within 24–48 h of preparation.
Chicken antisera production
Chickens were obtained as day-old chicks from a com-
mercial hatchery that was certified as being free of avian
influenza viruses by the Department of Animal Health
(DAH) in Hanoi, Vietnam. The antibody-negative status of
chickens was reconfirmed at 5 weeks of age, prior to being
used for antisera production, by testing with a commercial
NP ELISA Flock Check AI (Idexx Laboratories, Westbrook,
ME, USA). Five chickens were used per viral antigen for
antisera production. Briefly, chickens were immunized
subcutaneously in the nape of the neck with 0.5ml of
immunogen/adjuvant using a 5-ml syringe and a 22 gauge
needle. To produce antisera against commercial poultry
vaccines, vaccines were reconstituted as per manufacturer’s
instructions (Harbin Veterinary Research Institute, Harbin,
China). At 3 weeks post-immunization, chickens were
sedated by intravenous administration of ketamine/xylazine
based on body weight, and blood was collected by cardiac
puncture. Whole blood tubes were incubated for 3–5 h at 37
°C on their sides, after which they were placed at 4 °C
overnight to maximize serum volume. Sera were harvested
by centrifuging the samples to pellet the clots, after which
the supernatants were decanted and stored at −20 °C in 1-
ml aliquots until further use. Procedures for animal work at
the NCVD were adapted from the OIE (available at: http://
web.oie.int/eng/normes/mcode/en_chapitre_1.7.8.htm).
Ferret antisera production
Ferret antisera against the selected A(H5) viruses were
produced as previously described at the Centers for Dis-
ease Control and Prevention (CDC) Influenza Division in
Atlanta, GA, USA. Briefly, outbred male ferrets with body
weights ranging from 900 to 1800 g and less than one year
of age were obtained from Triple F Farms (Sayre, PA,
USA). Ferrets were confirmed as being antibody-negative
for influenza A and B viruses and were inoculated intra-
nasally (in) with doses ranging between 104 and 106 EID50
of live virus diluted in PBS. At 14 days post-inoculation,
each ferret was boosted by subcutaneous injection in both
hind legs with at least 1024 HAU of virus mixed with
Titermax Gold Adjuvant (Sigma-Aldrich, MO, USA).
Antisera were collected 14 days post-boost. All work with
animals was carried out in biosafety level 3 laboratories
with enhancements to meet USDA/APHIS guidelines and
performed under protocols approved by the Institutional
Animal Care and Use Committee of the CDC.
Comparison of chicken and ferret antisera via HI assays
Antigenic characterization was performed using the
post-infection ferret and chicken antisera in parallel. Sera
were heat inactivated at 56 °C for 30min, absorbed with
packed chicken red blood cells (CRBCs) to remove non-
specific agglutinators, and then tested through an HI assay
with 0.5% CRBCs following standard procedures19.
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Table 2 Viruses used in this study
Isolate name Abbreviation Viral status Clade Antigen type
1 A/goose/Guangdong/1/1996 GD/1/96 WT 0 Reference
2 A/Vietnam/1203/2004 VN/1203/04 WT 1 Reference
3 A/duck/Vietnam/NCVD-016/2007 DK/VN/016/07 WT 1.1 Referencea
4 A/Cambodia/R0405050/2007 CB/R0405050/07 WT 1.1 Reference
5 A/chicken/Vietnam/NCVD-1192/2012 CK/VN/1192/12 WT 1.1 Referencea
6 A/Indonesia/5/2005 INDO/5/05 WT 2.1.3.2 Test
7 A/Indonesia/5/2005 (CDC-RG2) INDO/5/05 RG2 RG 2.1.3.2 Reference
8 A/turkey/Turkey/1/2005 TK/1/05 WT 2.2.1 Reference
9 A/Egypt/321-Namru3/2007 EG/321/07 WT 2.2.1 Reference
10 A/Egypt/321-Namru3/2007 (IDCDC-RG11) EG/321/07 RG11 RG 2.2.1 Referencea
11 A/Egypt/N03072/2010 (IDCDC-RG29) EG/N03072/10 RG29 RG 2.2.1 Reference
12 A/common magpie/Hong Kong/5052/2007 CM/HK/5052/07 WT 2.3.2.1 Referencea
13 A/Hubei/1/2010 (IDCDC-RG30) HB/1/10 RG30 RG 2.3.2.1a Reference
14 A/chicken/Vietnam/NCVD-675/2011 CK/VN/675/11 WT 2.3.2.1a Referencea
15 A/duck/Vietnam/NCVD-1207/2012 DK/VN/1207/12 WT 2.3.2.1a Referencea
16 A/barn-swallow/Hong Kong/D10-1161/2010 BS/HK/1161/10 WT 2.3.2.1b Reference
17 A/duck/Vietnam/NCVD-672/2011 DK/VN/672/11 WT 2.3.2.1b Reference
18 A/duck/Vietnam/NCVD-1163/2012 DK/VN/1163/12 WT 2.3.2.1b Referencea
19 A/bar-headed goose/Mongolia/X53/2009 BG/MG/X53/09 WT 2.3.2.1c Referencea
20 A/Hong Kong/6841/2010 HK/6841/10 WT 2.3.2.1c Reference
21 A/duck/Vietnam/NCVD-1648/2012 DK/VN/1648/12 WT 2.3.2.1c Referencea
22 A/duck/Vietnam/NCVD-1544/2012 DK/VN/1544/12 WT 2.3.2.1c Reference
23 A/duck/Vietnam/NCVD-1584/2012 DK/VN/1584/12 WT 2.3.2.1c Referenceb
24 A/duck/Vietnam/NCVD-003/2008 DK/VN/003/08 WT 2.3.4 Referencea
25 A/duck/Vietnam/NCVD-391/2009 DK/VN/391/09 WT 2.3.4 Referencea
26 A/Japanese-white-eye/Hong Kong/1038/06 JW/HK/1038/06 WT 2.3.4 Referencea
27 A/chicken/India/NIV33487/2006 (IBCDC-RG7) CK/IND/NIV33487/06 RG7 RG 2.3.4 Referencea
28 A/Anhui/1/2005 ANH/1/05 RG 2.3.4 Reference
29 A/duck/Vietnam/NCVD-293/2009 DK/VN/293/09 WT 2.3.4.1 Reference
30 A/chicken/Vietnam/NCVD-35/2008 CK/VN/35/08 WT 2.3.4.2 Referencea
31 A/chicken/Vietnam/NCVD-279/2009 CK/VN/279/09 WT 2.3.4.3 Referencea
32 A/chicken/Vietnam/NCVD-016/2008 CK/VN/016/08 WT 7.1 Referencea
33 A/chicken/Vietnam/NCVD-016/2008 (IDCDC-RG12) CK/VN/016/08 RG12 RG 7.1 Referencea
34 A/chicken/Vietnam/NCVD-3/2008 (IDCDC-RG25A) CK/VN/3/08 RG25A RG 7.1 Reference
35 A/goose/Vietnam/113/2001 GS/VN/113/01 WT 3 Test
36 A/duck/Vietnam/NCVD-1/2002 DK/VN/1/02 WT 5 Test
37 A/whooper swan/Mongolia/244/2005 (Ag8) WS/MG/244/05 AG8 WT 2.2 Referenceb
38 A/duck/Vietnam/10/2005 DK/VN/10/05 WT 2.3.2 Test
39 A/duck/Vietnam/NCVD-19/2003 DK/VN/19/03 WT 1 Test
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Starting dilutions of 1:10 were used, and endpoint titers
were calculated as the reciprocal of the last HI positive
serum dilution. Naive, negative control sera from ferrets
and chickens were used in all HI tests to control for
potential background reactivity (data not shown).
Antigenic cartography
Antigenic cartography was performed as previously
described20 using the open access software available
through https://acmacs-web.antigenic-cartography.org/
. HI tables containing the full panel of HI titers
(homologous and heterologous) were first normalized
by calculating the difference between the log2 (HI titer)
of a given virus-serum pair and the maximum log2 (HI
titer) of that serum against a given virus. Antigenic
distances were calculated using multidimensional scal-
ing to minimize the differences between the target
distances and the distances in the antigenic map. Five-
hundred dimensional annealing runs were performed
for optimization, with random restarts implemented to
avoid being trapped in local optima. Metadata asso-
ciated with all reference and test antigens were pre-
pared in Microsoft Office Excel 2010 spreadsheets with
an antigen table (test virus, antigen ID, strain name,
clade, and abbreviation) and antisera table (test serum,
serum ID, serum strain, serum clade, abbreviation, and
serum type). Antigenic maps were visualized using
Tableau Reader v9.1 by importing x/y coordinate out-
put files and linking each coordinate with reference or
test antigen metadata.
HI data matrices
A total of 18 ferret antisera were used for cross-HI tests
with 15 homologous antigens and 25 test antigens.
Similarly, the 29 chicken antisera experimentally pro-
duced in this study were used for cross-HI testing with
their homologous antigens and 65 heterologous test
antigens (circulating field viruses) (Table 2). Post-
vaccination sera of Re-1 (A/goose/Guangdong/1/1996,
clade 0), Re-5 (A/duck/Anhui/1/2006, clade 2.3.4), and
Re-6 (A/duck/Guangdong/S1322/2006, clade 2.3.2.1b)
vaccines were titrated against the full complement of
antigens (29 reference viruses and 65 test antigens). For
14 viruses, we had access to both ferret and chicken
antisera raised against the same virus; these sera were
titrated against the 14 homologous antigens and 28 test
antigens.
Rationale of the HI test set-up
Following the conventions and terminology of anti-
genic characterizations of serological data sets, we refer
to ‘two-way’ vs. ‘one-way’ analyses of HI titer matrices.
Two-way analyses refer to interpretations of antigenic
relationships based on complete data sets, where each
virus is represented by both an antigen and its homo-
logous antiserum. For two-way analyses, the spatial
coordinates for a given antigen or antiserum reflect the
differential reactivity to both homologous and hetero-
logous viruses. For the purposes of comparing chicken
vs. ferret models, we first performed two-way analyses to
assess whether the chicken and ferret models generated
antisera with comparable specificities. In contrast to
‘two-way’ analyses, a ‘one-way’ analysis involves inter-
pretation of antigenic relationships when a given virus is
represented solely by the viral antigen because no
homologous antiserum has been produced (in this case
the antigens are called ‘test’ antigens). For one-way
analyses, the spatial coordinates for a given antigen are
Table 2 continued
Isolate name Abbreviation Viral status Clade Antigen type
40 A/duck/Vietnam/NCVD-2153/2012 DK/VN/2153/12 WT 1.1.2 Test
41 A/chicken/Vietnam/NCVD-2750/2013 CK/VN/2750/13 WT 1.1.2 Test
42 A/chicken/Vietnam/NCVD-1096/2013 CK/VN/1096/13 WT 7.2 Test
43 A/chicken/Vietnam/NCVD-93/2008 CK/VN/93/08 WT 7.2 Test
44 A/chicken/Vietnam/NCVD-2749/2013 CK/VN/2749/13 WT 2.3.2.1a Test
45 A/chicken/Vietnam/NCVD-2693/2013 CK/VN/2693/13 WT 2.3.2.1b Test
46 A/duck/Vietnam/NCVD-2745/2013 DK/VN/2745/13 WT 2.3.2.1c Test
47 A/chicken/Vietnam/NCVD-14-A318/2014 CK/VN/A318/14 WT 2.3.2.1c Test
48 A/duck/Vietnam/NCVD-14-A332/2014 DK/VN/A332/14 WT 2.3.2.1c Test
Antigens were produced in embryonating chicken eggs for all strains. Chicken antisera were produced for strains and were designated as ‘reference’ antigens
WT wild type, RG viruses produced by reverse genetics with PR8 internal genes and with the polybasic cleavage site removed from the HA protein
aReference antigen for the chicken model only
bReference antigen for the ferret model only
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derived from the combined reactivity of a given antigen
to a panel of heterologous antisera. The most common
scenario for cartography is to have a small number of
reference antigens and a much larger number of test
antigens because antisera are expensive and time-
consuming to generate.
Plotting of antigenic distances to in vivo vaccine efficacy
Antigenic distances, calculated from chicken antisera-
based HI tests, between viruses previously tested in vac-
cine challenge studies and each of three poultry vaccines
(i.e., Re-1, Re-5, and Re-6) were calculated as above. The
distances were plotted against the percent survival of
chickens that were vaccinated and challenged with the
corresponding vaccine and virus. The methodology and
results from the vaccine challenge studies were previously
described6–9.
Chicken challenge studies
The commercial inactivated H5N1 Re-1, Re-5 and Re-
6 poultry vaccines, which were previously and currently
used in Vietnam and produced by the Harbin Veter-
inary Research Institute (People’s Republic of China),
were used to vaccinate chickens. Chickens were
obtained at one day of age from a commercial hatchery.
Serum samples were collected from 20 chickens in each
experiment to ascertain that the birds were serologically
negative for antibodies to the NP protein of influenza A
viruses as determined by the commercial ELISA test
Flock Check AI (Idexx Laboratories, Westbrook, ME).
Two-week-old chickens (20 chickens/group) were vac-
cinated subcutaneously in the nape of the neck with 0.5
ml of the Re-1, Re-5 or Re-6 vaccines. This vaccination
schedule was based on the manufacturer’s recommen-
dations. In each experiment, an additional 10 chickens
were not vaccinated and served as the challenge
controls.
Three weeks after vaccination, blood samples were
collected and tested by hemagglutinin tests (HI) with
inactivated antigens of A/VN/1203/2004 (for the Re-1
vaccinated chicken group), A/Anhui/1/2005 (for the Re-5
vaccinated chicken group), and A/Hubei/1/2010 (for the
Re-6 vaccinated chicken group). Ten chickens with HI
titers ≥ 3 log2 from each vaccinated group were selected
for challenge experiments, which were inoculated intra-
nasally with 106 TCID50 of the selected H5 HPAI chal-
lenge virus. Chickens were observed daily for clinical signs
and mortality. Oropharyngeal and cloacal swabs were
collected at different days post challenge (dpc) to assess
viral shedding. At the end of each experiment (10 days),
blood was collected from all surviving chickens for anti-
body assays. All experiments were performed in biosafety
level two plus enhanced facilities at the National Centre
for Veterinary Diagnostics.
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